Abnormal lipid profile in the context of liver steatosis measured by transient elastography: experiences from an outpatient endocrine clinic

瞬时弹性成像测量肝脂肪变性背景下的异常血脂谱:来自门诊内分泌诊所的经验

阅读:2

Abstract

BACKGROUND: Dyslipidaemia is a recognised risk factor for cardiovascular diseases which remain the leading cause of death worldwide. There is a knowledge gap whether the prevalence/pattern of dyslipidaemia depends on the aetiology of the liver disease. OBJECTIVE: To evaluate the association between dyslipidaemia and chronic liver diseases. METHODS: A cross-sectional study included adults aged ≥ 18 years, who attended outpatient Endocrine clinic between January 2023 and April 2025. Patients who underwent both transient elastography and lipid profile measurement were included in the analysis. Data on participants’ demographics, history of glucose intolerance, statin treatment, liver function tests, and non-invasive liver fibrosis markers were recorded. Descriptive statistics and binary logistic regression were performed to study the associations. RESULTS: The study included 329 participants (aged 47 ± 14 years, 53.8% males), of whom 68.4% had steatotic liver disease (SLD) and 23.1% had viral hepatitis. Dyslipidaemia was associated with higher mean of controlled attenuation parameter (CAP) (297.4 ± 49.8 vs. 267.2 ± 56.9, P = 0.002) and higher prevalence of liver steatosis (91.7% vs. 72.1%, P < 0.001). 90.9% of participants with dyslipidaemia had SLD, whereas only 72.1% of those with optimal lipid profile had SLD (P < 0.001). In the univariable (bivariate) analysis, CAP was significantly associated with dyslipidaemia (OR = 1.01, 95%CI = 1.01–1.02, P < 0.001). The final multivariable logistic regression retained CAP as the predictor of dyslipidaemia (aOR = 1.02, 95%CI = 1.01–1.04, P = 0.001). CONCLUSIONS: The findings suggest that dyslipidaemia is common among individuals with steatotic liver disease and is associated with hepatic steatosis quantified by CAP, rather than fibrosis. These findings highlight the importance of accessible, non-invasive diagnostic approaches in strengthening preventive and management approaches in routine clinical settings. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-025-02849-3.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。